BIOGENERATION III SERVICES B.V.
BIOGENERATION III SERVICES B.V. is a Pre-seed, Seed, Series A and Series C+ fund in Europe and Benelux writing $100K–$1M checks into Healthcare, therapeutics, medical-devices and enabling-technologies.
- Stages
- Pre-seed, Seed, Series A, Series C+
- Sectors
- Healthcare, therapeutics, medical-devices, enabling-technologies
- Check size
- $100K–$1M
- Invests in
- Europe, Benelux
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2024
- Assets under management
- €250M
- Website
- biogeneration.vc
Thesis
BioGeneration III Services B.V. (BGV III) is a Dutch venture capital firm established in 2024, focusing on early-stage investments in European life sciences. The firm targets seed and Series A rounds, with a specific interest in preclinical to early-clinical-stage therapeutics, medical devices, and enabling technologies. BGV III prioritizes academic spin-outs from Benelux institutions, seeking companies with unpartnered intellectual property and reasonable valuations. The firm typically acts as a lead investor, providing hands-on guidance. The geographic focus is primarily Europe, with a strong emphasis on the Benelux region. BGV III's third fund closed at €82 million, exceeding its target. The typical check size ranges from €100,000 to €1,000,000, with a sweet spot of €500,000, aiming for approximately 10 participations. The broader BioGeneration Ventures platform has €250 million in AUM. The fund also considers environmental or social characteristics aligned with SDGs 3 and 8.
Common questions
Does BIOGENERATION III SERVICES B.V. invest at the Pre-seed stage?
Yes. BIOGENERATION III SERVICES B.V. lists Pre-seed, Seed, Series A and Series C+ among the stages it invests in.
What check size does BIOGENERATION III SERVICES B.V. write?
BIOGENERATION III SERVICES B.V. writes $100K–$1M checks.
Where does BIOGENERATION III SERVICES B.V. invest?
BIOGENERATION III SERVICES B.V. invests in Europe and Benelux.